Bio-Works Technologies

Bio-Works Receives Order Worth SEK 2.4 Million from New European Customer in Vaccine Production

REG

"We see it as a strong endorsement that a new player in vaccine production chooses Bio-Works as a supplier. This strengthens our position in the European market," says Lone Carlbom, CEO of Bio-Works Technologies AB.

The delivery concerns products used in the production process and represents a potential for long-term collaboration.

This disclosure contains information that Bio-Works Technologies AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014) and the Swedish Securities Markets Act (2007:528). The information was submitted for publication, through the agency of the contact person, on 29-04-2025 16:04 CET.

Datum 2025-04-29, kl 16:04
Källa Cision
Bifogade filer
Hej Serverägare! Har du problem med troll och spam? Nu finns möjligheten att sätta en liten avgift, t.ex. 20kr, på discord invites och därmed stoppa många återkommande troll samtidigt som du tjänar lite pengar. Kolla in Invite Paywall.